Analabs Berhad announced that it had acquired quoted securities in Malayan Banking Berhad during the period from 28 August 2024 to 30 August 2024 for which the aggregate of the purchase consideration amounting to RM22.9 million.

The total acquisitions has now exceeded 5% the group's total audited consolidated net assets as at 30 April 2024.

The company said the acquisitions was carried out with the intention of deriving dividend income and for potential capital gains.